AstraZeneca vaccine less effective against S.African strain: study

The University of Witwatersrand, Johannesburg, which conducted the trial, said in a statement that the vaccine "provides minimal protection against mild-moderate Covid-19 infection" from the variant.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3pZnUfZ
via IFTTT